Amneal Pharmaceuticals (NASDAQ:AMRX) reported fourth-quarter and full-year 2025 results and outlined its 2026 outlook, ...

As one long-running feud over the controversial generic drug carveout known as “skinny” labeling comes to a close, the United States’ top lawyer is urging the Supreme Court to reverse a recent ...

If anti-Israel agitators wish to avoid being described as terrorists, they might begin by ceasing to terrorise ordinary people.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy healthcare stocks to invest in. Teva ...

" data-display-label="0" data-show-count="1" data-bookmark-label="Save" data-bookmarked-label="Saved" data-loggedin="0" data-type="post" data-object_id="360910" class="cbxwpbkmarktrig ...

Allspring SMID Cap Growth Fund reports on Q4 market rotations and performance drivers like Teva and Natera. Read the full ...

Allspring SMID Cap Growth Fund reviews Q4 2025 performance and identifies high-quality growth opportunities. Read the full ...

Eleven community-based organizations were selected as the first recipients of Baltimore City's Opioid Restitution Fund community grants.

On February 23, Steven Wieting, CIO Group chief investment strategist, appeared on CNBC’s ‘The Exchange’ to talk about the ...

In a statement issued to media, Teva, who employ 650 workers in Waterford, said: “Teva can confirm that we have initiated a ...

Revenue growth of 13% in 2025 was driven by a record surge in demand, though tablet volume lagged behind new prescriptions ...